Neurocrine Biosciences Ownership | Who Owns Neurocrine Biosciences?


OverviewForecastRevenueFinancialsChartTranscripts

Neurocrine Biosciences Ownership Summary


Neurocrine Biosciences is owned by 94.39% institutional investors, 1.10% insiders, and 4.51% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.62% of NBIX shares. Dodge & Cox Stock I is the top mutual fund, with 3.98% of its assets in Neurocrine Biosciences shares.

NBIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNeurocrine Biosciences94.39%1.10%4.51%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustrySpecialty & Generic Drug Manufacturers Stocks2774.71%11.85%-2686.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de14.78M14.62%$2.02B
Blackrock14.19M14.22%$1.95B
Vanguard group10.12M10.01%$1.38B
State street4.61M4.62%$634.43M
Dodge & cox3.02M2.98%$411.74M
Renaissance2.49M2.46%$339.80M
Aqr capital management1.90M1.88%$258.93M
Geode capital management1.88M1.85%$255.52M
Bellevue group1.82M1.80%$248.43M
Morgan stanley1.54M1.55%$212.68M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sarissa capital management lp309.12K13.07%$42.19M
Eagle health investments lp155.00K5.19%$21.16M
Bellevue group1.82M4.78%$248.43M
Healthinvest partners ab67.76K4.41%$9.29M
Rock springs capital management lp720.50K3.74%$98.35M
Braidwell lp901.79K3.65%$123.09M
Birchview capital, lp30.24K3.36%$4.13M
Avidity partners management lp220.40K2.95%$30.08M
Orbimed advisors938.12K2.64%$128.05M
Dafna capital management71.61K2.48%$9.78M

Top Buyers

HolderShares% AssetsChange
Dodge & cox3.02M0.24%1.73M
Raymond james financial843.90K0.04%843.90K
Wellington management group llp1.46M0.04%739.20K
Thrivent financial for lutherans737.77K0.20%711.97K
Armistice capital892.00K1.66%710.62K

Top Sellers

HolderShares% AssetsChange
Dsm capital partners---932.60K
Point72 asset management---837.43K
Vestal point capital, lp---710.00K
Jupiter asset management---582.79K
Morgan stanley1.54M0.02%-520.77K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial843.90K0.04%843.90K$115.19M
Norges bank325.30K0.01%325.30K$44.40M
Balyasny asset management194.73K0.04%194.73K$26.58M
Fjarde ap-fonden (the fourth swedish national pensionfund)49.82K0.08%49.82K$6.86M
New age alpha advisors22.36K0.12%22.36K$3.05M

Sold Out

HolderChange
Rosenberg matthew hamilton-4.00
Tfc financial management-4.00
Dt investment partners-5.00
Fortitude family office-6.00
Newsquare capital-7.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025585-3.94%94,105,380-0.29%941.07%246-24.31%25722.38%
Dec 31, 2024555-5.77%87,755,246-5.34%861.03%288-3.36%196-2.97%
Sep 30, 2024585-3.31%92,570,293-1.20%911.06%297-9.17%2006.38%
Jun 30, 2024596-0.83%93,638,1690.75%931.08%3211.90%187-10.10%
Mar 31, 20246017.71%92,944,0710.73%931.04%3155.35%2087.22%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dodge & Cox Stock I3.96M3.98%1.89M
iShares Core S&P Mid-Cap ETF3.24M3.27%2.12K
Vanguard Total Stock Mkt Idx Inv3.20M3.24%48.87K
Vanguard US Total Market Shares ETF3.20M3.21%2.53K
Vanguard Small Cap Index2.50M2.53%14.59K
BB Biotech AG Ord1.82M1.80%-40.00K
Vanguard Institutional Extnd Mkt Idx Tr1.54M1.56%8.59K
Vanguard Small Cap Growth Index Inv1.39M1.41%-1.60K
Vanguard Windsor Investor Shares1.14M1.15%402.44K
SPDR® S&P Biotech ETF1.12M1.13%1.45K

Recent Insider Transactions


DateNameRoleActivityValue
May 27, 2025GORMAN KEVIN CHARLES-Sell$1.16M
May 05, 2025RASTETTER WILLIAM H-Sell$3.31M
Feb 13, 2025Cooke Julie Chief Human Resources OfficerSell$92.95K
Feb 13, 2025Cooke Julie Chief Human Resources OfficerSell$88.18K
Feb 13, 2025GORMAN KEVIN CHARLES-Sell$351.45K

Insider Transactions Trends


DateBuySell
2025 Q2-2
2025 Q1-45
2024 Q4-4
2024 Q3-18
2024 Q2-12

NBIX Ownership FAQ


Who Owns Neurocrine Biosciences?

Neurocrine Biosciences shareholders are primarily institutional investors at 94.39%, followed by 1.10% insiders and 4.51% retail investors. The average institutional ownership in Neurocrine Biosciences's industry, Specialty & Generic Drug Manufacturers Stocks, is 2774.71%, which Neurocrine Biosciences falls below.

Who owns the most shares of Neurocrine Biosciences?

Neurocrine Biosciences’s largest shareholders are Blackrock funding, inc. /de (14.78M shares, 14.62%), Blackrock (14.19M shares, 14.22%), and Vanguard group (10.12M shares, 10.01%). Together, they hold 38.85% of Neurocrine Biosciences’s total shares outstanding.

Does Blackrock own Neurocrine Biosciences?

Yes, BlackRock owns 14.22% of Neurocrine Biosciences, totaling 14.19M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.95B$. In the last quarter, BlackRock increased its holdings by 429.74K shares, a 3.12% change.

Who is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Neurocrine Biosciences’s biggest shareholder by percentage of total assets invested, with 13.07% of its assets in 309.12K Neurocrine Biosciences shares, valued at 42.19M$.

Who is the top mutual fund holder of Neurocrine Biosciences shares?

Dodge & Cox Stock I is the top mutual fund holder of Neurocrine Biosciences shares, with 3.98% of its total shares outstanding invested in 3.96M Neurocrine Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools